153 related articles for article (PubMed ID: 2977989)
21. Thyrotropin-releasing hormone (TRH) blocks glucagon-induced hyperglycemia in mice: dissociation of the antihyperglycemic and pituitary actions of TRH.
Amir S
Brain Res; 1988 Jul; 455(1):201-3. PubMed ID: 3138000
[TBL] [Abstract][Full Text] [Related]
22. Re-evaluation of histidyl-proline diketopiperazine [cyclo(His-Pro)] effects on food intake in the rat.
Bowden CR; Karkanias CD; Bean AJ
Pharmacol Biochem Behav; 1988 Feb; 29(2):357-63. PubMed ID: 3129742
[TBL] [Abstract][Full Text] [Related]
23. Cyclo(His-Pro) concentration. Changes in brain striatum of hyperglycemic rat.
Mori M; Iriuchijima T; Yamada M
Diabetes; 1988 Aug; 37(8):1120-2. PubMed ID: 2839388
[TBL] [Abstract][Full Text] [Related]
24. Thyrotropin-releasing hormone increases plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
Knudtzon J
Horm Metab Res; 1981 Jul; 13(7):371-5. PubMed ID: 6792023
[TBL] [Abstract][Full Text] [Related]
25. Role of peripheral and central catecholaminergic and cholinergic mechanisms in the cardiovascular effects of thyrotropin-releasing hormone.
Nurminen ML; Paakkari I
Neuropeptides; 1991 Dec; 20(4):247-53. PubMed ID: 1667428
[TBL] [Abstract][Full Text] [Related]
26. TRH analogue, RX 77368, injected into dorsal vagal complex stimulates gastric secretion in rats.
Stephens RL; Ishikawa T; Weiner H; Novin D; Taché Y
Am J Physiol; 1988 May; 254(5 Pt 1):G639-43. PubMed ID: 3129948
[TBL] [Abstract][Full Text] [Related]
27. Afferent vagal fibres and central cholinergic mechanisms are involved in the TRH-induced reversal of haemorrhagic shock.
Vergoni AV; Marrama D; Guarini S; Tagliavini S; Bazzani C; Maugeri A; Bertolini A
Pharmacol Res; 1991 Apr; 23(3):271-8. PubMed ID: 1906171
[TBL] [Abstract][Full Text] [Related]
28. Thyrotropin-releasing hormone blocks neurally-mediated hyperglycemia through central action.
Amir S; Butler PD
Peptides; 1988; 9(1):31-5. PubMed ID: 2896345
[TBL] [Abstract][Full Text] [Related]
29. Effect of intracerebroventricular administration of thyrotropin-releasing hormone upon the electroenteromyogram of rat duodenum.
Tonoue T; Nomoto T
Eur J Pharmacol; 1979 Oct; 58(4):369-77. PubMed ID: 116857
[TBL] [Abstract][Full Text] [Related]
30. Central effects of DN1417, a novel TRH analog, on plasma glucose and catecholamines in conscious rats.
Kabayama Y; Kato Y; Tojo K; Shimatsu A; Ohta H; Imura H
Life Sci; 1985 Apr; 36(13):1287-94. PubMed ID: 2858799
[TBL] [Abstract][Full Text] [Related]
31. Central interleukin 1-elicited hyperinsulinemia is mediated by prostaglandins but not autonomics.
Cornell RP
Am J Physiol; 1989 Oct; 257(4 Pt 2):R839-46. PubMed ID: 2572177
[TBL] [Abstract][Full Text] [Related]
32. Thyrotropin releasing hormone but not histidyl-proline diketopiperazine is depleted from rat spinal cord following 5,7-dihydroxytryptamine treatment.
Lechan RM; Jackson IM
Brain Res; 1985 Feb; 326(1):152-5. PubMed ID: 3918765
[TBL] [Abstract][Full Text] [Related]
33. Lack of effect of thyrotropin-releasing hormone (TRH) on the peripheral plasma levels of pancreatic glucagon in man.
Usman A; Istanbullu S
Horm Metab Res; 1986 Apr; 18(4):256-9. PubMed ID: 3086200
[TBL] [Abstract][Full Text] [Related]
34. The effect of intracisternal injection of thyrotropin-releasing hormone on gastric and duodenal motility in the urethane-anaesthetized rat.
Davison JS; Wootton P
Exp Physiol; 1991 Nov; 76(6):983-6. PubMed ID: 1768421
[TBL] [Abstract][Full Text] [Related]
35. Increase in plasma glucose concentration after intracerebroventricular injection of N,O'-dibutyryl cyclic adenosine 3',5'-monophosphate.
Iguchi A; Gotoh M; Matsunaga H; Ohuchi M; Nomura T; Sakamoto N
Endocrinology; 1986 Jul; 119(1):125-9. PubMed ID: 2873022
[TBL] [Abstract][Full Text] [Related]
36. Role of thyrotropin-releasing hormone in stress ulcer formation in the rat.
Basso N; Bagarani M; Pekary AE; Genco A; Materia A
Dig Dis Sci; 1988 Jul; 33(7):819-23. PubMed ID: 3132357
[TBL] [Abstract][Full Text] [Related]
37. Suppression of the pressor effect of centrally administered thyrotropin-releasing hormone under halothane, pentobarbital and flunitrazepam anaesthesia.
Tanaka H; Okuda C; Sawa T; Mizobe T; Demura H; Miyazaki M
Acta Anaesthesiol Scand; 1988 Oct; 32(7):535-40. PubMed ID: 3142198
[TBL] [Abstract][Full Text] [Related]
38. Effects of intrathecal administration of thyrotropin releasing hormone and its analogue, DN1417, on plasma glucose and catecholamine levels in conscious rats.
Ishikawa Y; Shimatsu A; Kato Y; Murakami Y; Imura H
Brain Res; 1990 Apr; 514(1):1-4. PubMed ID: 2113409
[TBL] [Abstract][Full Text] [Related]
39. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
Helke CJ; Phillips ET
J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544
[TBL] [Abstract][Full Text] [Related]
40. Central nervous system mediated stimulation by thyrotropin-releasing hormone of microcirculation in thyroid gland of rats.
Tonoue T; Nomoto T
Endocrinol Jpn; 1979 Dec; 26(6):749-52. PubMed ID: 120247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
